FDA Memo Links COVID-19 Vaccines to 10 Child Deaths, Prompting Calls for Stricter Vaccine Oversight

An internal memo from the U.S. Food and Drug Administration (FDA) has linked at least 10 child deaths to COVID-19 vaccinations, citing myocarditis—a form of heart inflammation—as a potential cause. The memo, authored by Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, suggests that these findings will lead to stricter vaccine approval processes.

The memo indicates that a review of 96 deaths reported to the Vaccine Adverse Event Reporting System (VAERS) between 2021 and 2024 found that "no fewer than 10 are related" to COVID-19 vaccinations. However, the document does not provide specific details such as the ages or health conditions of the children, nor does it identify the vaccine manufacturers involved.

In response to these findings, Dr. Prasad announced plans to tighten vaccine oversight, including requiring more comprehensive data for vaccines administered during pregnancy and reevaluating the regulation of annual influenza vaccines. He also mentioned that the FDA may reconsider the practice of administering multiple vaccines simultaneously, a change that could impact the current childhood vaccination schedule.

The memo has elicited skepticism from various experts. Dr. Paul Offit, a professor at Children's Hospital of Philadelphia, described the memo as "irresponsible" and "dangerous," emphasizing the need for extraordinary evidence to support such claims. Similarly, Dr. Peter Marks, the FDA's former vaccine chief, expressed concern over the memo's "clearly political tone" and noted that the case reports of child deaths require further investigation.

The FDA has not yet published these findings in a peer-reviewed medical journal, and it remains unclear what the agency's next steps will be. The Centers for Disease Control and Prevention's vaccine committee is expected to review the findings in an upcoming meeting.